Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$1.8 million.

  • Strata Critical Medical's Cash from Financing Activities fell 14445.96% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.0 million, marking a year-over-year decrease of 47882.6%. This contributed to the annual value of -$5.8 million for FY2024, which is 747763.16% down from last year.
  • Per Strata Critical Medical's latest filing, its Cash from Financing Activities stood at -$1.8 million for Q3 2025, which was down 14445.96% from -$1.1 million recorded in Q2 2025.
  • Strata Critical Medical's Cash from Financing Activities' 5-year high stood at $333.5 million during Q2 2021, with a 5-year trough of -$4.2 million in Q1 2025.
  • Over the past 5 years, Strata Critical Medical's median Cash from Financing Activities value was -$731000.0 (recorded in 2024), while the average stood at $18.5 million.
  • Per our database at Business Quant, Strata Critical Medical's Cash from Financing Activities skyrocketed by 171000.0% in 2021 and then plummeted by 1674347.83% in 2024.
  • Over the past 5 years, Strata Critical Medical's Cash from Financing Activities (Quarter) stood at -$3.0 million in 2021, then skyrocketed by 68.51% to -$932000.0 in 2022, then surged by 97.53% to -$23000.0 in 2023, then crashed by 16743.48% to -$3.9 million in 2024, then skyrocketed by 53.87% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q3 2025, -$1.1 million for Q2 2025, and -$4.2 million during Q1 2025.